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Endovascular coiling has been widely used for treatment of intracranial aneurysms. Platinum coils are typically used at a packing density sufficient to cause occlusion of the aneurysm sac 3 . A typical medium to large intracranial aneurysm coiling procedure uses framing (stiff), filling and finishing (soft) coils -in that order. One of the worst risks associated with endovascular coiling is intraprocedure aneurysm rupture (IAR) 2, 5, 9 . Although the IAR occurence is low (1-8%), it markedly increases the risk of morbidity and mortality 9 . This has been broadly correlated to aneurysm size 12 and certain aneurysm locations 9 that are associated with a higher perforation risk during intervention with guidewires, microcatheters and coils 6 .
There is also a limited IAR dependence on coil placement sequence as well as microcatheter placement and tracking. For instance, in some cases IAR occurence has been reported during placement of the first coil 6 (usually a framing coil) or during subsequent coils 15 (in some instances this could be attributed to overpacking). IAR is also seen both with soft coils 7 in addition to framing coils 5 . From histological postmortem evaluations, the average wall thickness of an intracranial aneurysm is approximately 50 microns 1 .
The intracranial aneurysm wall structure is heterogeneous and the thickness has been shown to be inversely correlated to localized wall shear stress (and thereby rupture risk) 4, 13 . Therefore, the localized force exerted on the aneurysm wall during interventions should be minimized. Proper coil selection in addition to the rate of deployment of coils (with visual feedback) could be one of the factors for minimizing IAR risk.
Previous reports have quantified the average force on the aneurysm wall during coil deployment in an in vitro setting 10, 11 . These reports show the stiffness differences that are apparent between framing and filling coils and also show a correlation between distal force exerted on the aneurysm wall and the proximal push force used to deliver the coil 10 . A limitation in these measurements was either the use of a straight vessel anatomy leading upto the aneurysm 10 or the measurement of only the proximal push force to deliver the coil 11 . Coil stiffness surrogates such as first principles calculation using Hookean assumptions 16 or a measure of final packing density of the coils in the aneurysm 14 , have also been
proposed. These latter methods, however, may be limited in not being able to demonstrate the higher order effects associated with coil structure and deployment in a physiological aneurysm model.
We report here a clinically relevant in vitro method to measure coil softness ("pliability") and compare two commercial products -both in the framing and filling coils categories. The two filling coils evaluated were Axium™ Prime ES Coil (Medtronic, Irvine, CA) and The Target™ 360 Nano Coil (Stryker, Fremont, CA). The ES coil was designed for smooth transitions within the aneurysm and this is facilitated with a smaller wire diameter (0.0013 inch primary wire and 0.0011 inch stretch resistant strand diameters). The Target™ 360 Nano Coil (Stryker, Fremont, CA) has a flexible primary wire to reduce the coil stiffness and is therefore often recommended as a finishing coil. The two framing coils evaluated
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A C C E P T E D M A N U S C R I P T We utilize an energy based metric (area of the force-displacement curve; reported as "average work number or AWN") to quantify the differences between the coils in each category. This metric represents a product of the measured components of force perpendicular to the aneurysm neck (near the top of the aneurysm dome), and the length of coil delivered (for a single coil).
MATERIALS AND METHODS Coils
Two commercially available coils in framing and filling segments were compared -(a) Soft coil group:
Axium™ Prime ES Coil (2.5mm x 4cm, Medtronic, N=20) and Target™ 360 Nano Coil (2.5mm x 4cm, Stryker, N=20) were delivered into the aneurysm model and force-displacement data was measured. Each 
Coil Pliability Measurement Experimental Setup
The test setup consisted of a commercially available automated tracking and measurement system The distal force sensor was calibrated against known standards prior to the evaluations with the coils.
For each test run, the coils were inserted manually into an 0.021 in ID Echelon microcatheter (Medtronic, Irvine, CA) until the distal end arrived at the entrance of aneurysm model and did not advance past the neck of the aneurysm as mentioned previously. Thereafter the deployment of coils into the aneurysm was ACCEPTED MANUSCRIPT
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controlled with a programmable motor (no human intervention) as per pre-specified inputs. The deployment rate and total deployment length was pre-programmed as followed: (a) Soft coil group: 5 cm/min rate and 3.75 cm length, and (b) Frame coil group: 10 cm/min rate and 14 cm length. The distal force sensor recorded the perpendicular components of the force exerted by the coil against the aneurysm wall simultaneously as soon as the roller started to push the delivery wire. Force data was captured at a frequency of 16 Hz and combined with the video capture (visual) data for analysis later.
Force-Displacement Data Analysis
The distal force measured for each coil during deployment against the aneurysm wall was quantified as a force-displacement curve. Peaks in the curve may be indicative of certain design characteristics of the coils -such as stiffness of coil loops, oversizing or sequential packing, and difficulty of turning or steering within the aneurysm.
We quantified and reported an averaged energy metric (Average Work Number or AWN) that can be calculated as the area under each force-displacement curve (gf-cm). Smaller AWN therefore translates to le ss force exerted by the coil on the wall during deployment and represents a measure of pliability of the coil.
Statistical Analysis
A normality test was conducted for the AWN data. Non-normal data was transformed per Johnson's transformation prior to statistical analysis with ANOVA. Post-hoc Fishers t test was conducted to identify differences between the 4 coils in the study. A significance level of 0.05 was used for all tests.
RESULTS
ANOVA for AWN showed a significant difference (p<0.001) between the coils evaluated. The results for the individual groups are described below.
Soft coil group: Axium™ Prime ES Coil and Target™ 360 Nano Coil
A sequential force-displacement graph showing the 3 phases (initial deployment, mid deployment and end of deployment) for a representative ES Coil and a Nano Coil are illustrated in Figure 2 The averaged (N=20) force-displacement curve for each coil is shown in Figure 3a . The AWN for the Axium™ Prime ES Coil was measured as 0.53 ± 0.09 gf-cm compared with 0.99 ± 0.21 gf-cm for the Target™360 Nano Coil (Figure 4 ). Post-hoc Fishers t-test for AWN showed significant difference between the two coils (p<0.001).
Frame coil group: Axium™ Prime FC Coil and Target™ 360 Standard Coil
The averaged (N=20) force-displacement curve for each coil is shown in Figure 3b The Standard coil appears to offer significant resistance to rearrangement within the aneurysm sac.
Conversely, the loops in the FC coils appear to rotate more smoothly and rearrange within the available aneurysm sac volume. With the Standard coil, compartmentalization may occur within the aneurysm and may account for the higher magnitude of force gradients (Figure 3b ) as opposed to a stable "basket" like structure with the FC coil resulting in lower force gradients.
DISCUSSION
Coil softness during deployment in an aneurysm is usually a subjective feeling and can vary between interventionists. Stiffness of a coil is often defined by the spring constant of the secondary structure due to the similarity of the coil structure to a spring in appearance 16 . However, the coil is not compressed to fill the aneurysm during a clinical endovascular procedure -instead -it is often bent to fit the limited space within the aneurysm sac. It is therefore much easier to bend a coil than to compress it, and for this reason, one can hardly compress a spring without buckling it first 8 . The final coil structure and especially the coil behavior and its engagement with the aneurysm wall during deployment (higher order effects) are not considered in the simple stiffness (force constant K) calculation. This theoretical coil stiffness factor (K)
can be calculated as follows 16 :
A where, D 1 is the coil wire diameter, G is the shear modulus of the coil wire, D 2 is primary coil outer diameter (OD), and n is the number of windings per unit distance. The theoretical coil stiffness (K factor) of the two coil groups is shown in Table 1 . This K factor calculation shows that the Target coils should be theoretically stiffer than the Axium coils. Our experimental analysis performed at a constant rate of deployment with the two coil groups and coil types confirms this trend for coil stiffness: Target Standard > Axium FC > Target Nano > Axium ES (Figure 4) . The ease deformation of a coil within an aneurysm is multifactorial and may be influenced by the thickness of the Polypropylene (PP) filament (stretch resistant member), coil loop diameter, and secondary shape, besides others. Axium™ Prime ES Coil has a smaller loop diameter (2.221 mm) compared to the Nano Coil (3.634 mm) and therefore may encounter less loop compression within the aneurysm sac. Additionally, the thinner filament of the Axium coils relative to the Target coils (Table 1 ) may result in the lower force observed (Figure 3a and 3b) when the coils start to bend and rearrange within the available aneurysm volume.
Higher order effects like the secondary and tertiary structure of the coil and conformability to the aneurysm sac may also account for the offset seen between Axium and Target coils in the two coil groups.
For instance, the Target™ 360 Standard Coil has a nominal loop OD of 5.577mm (Table 1) and a wellknown pre-determining secondary shape feature due to its closed loop design. The more each progressive coil loop is compressed during deployment, the higher will be corresponding compression force against the aneurysm wall. This may lead to stacking together of the loops within the aneurysm and cause compartmentalization (non-uniform coil loop distribution). This feature may be notable during the current evaluation as the increased resistance with progressive coil deployment is also apparent in the corresponding peaks observed in the force-displacement curve (Figure 3b) . The resistance to coil rearrangement may be less prominent with the Axium FC coils presumably due to the 3D shape design.
This design may allow the progressive coil loops to support each other and make the frame stable allowing less resistance during rotation and improved conformability to the aneurysm wall.
Another notable feature is the difference in peak force towards the end of the loop. This is more apparent for the Standard Coil and Nano Coil as opposed to the FC Coil and ES Coil. Higher forces towards the end of deployment or aneurysm fill could potentially result in loops herniating inside the parent vessel -a notable limitation requiring the use of bridging stents to mitigate. Conversely, lower forces towards the end of deployment will allow progressive packing of the aneurysm closer to the neckwith less chances of loop herniation into the parent vessel.
The combination of tactile and visual feedback during embolization with coils remains a ACCEPTED MANUSCRIPT
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challenge. This is because it is often difficult to discern small magnitude of forces that may potentially cause IAR. This tactile feedback remains subjective and can vastly differ between operators. Therefore, it is imperative to address these issues better at the coil design stage. We have demonstrated in this manuscript the utility of an in vitro pliability test that allows investigation of coil design attributes and the specific impact on overall safety of delivery within an aneurysm that could mitigate or prevent IAR. We have also demonstrated a proof-of-concept feasibility of the test method by comparing the effect of primary design features of two commercially available coils on overall coil delivery performance. The difference in AWN measurements illustrate the impact that minor dimensional and structural differences may have on overall coil performance and procedural safety.
We acknowledge that our method has significant limitations and departs from the clinical use of coils as follows: (a) coils were delivered at a pre-programmed constant rate into the aneurysm -clinically an operator may choose to slow down based on the visual and often less perceptible tactile feedback, (b) a rigid acrylic aneurysm model was utilized as opposed to a material with mechanical properties similar to the aneurysm wall, (c) the microcatheter was placed at the neck of the aneurysm to remove the influence of microcatheter movement on the forces being measured, (d) there was no physiological blood flow during deployment, (e) measurements were conducted at only one representative coil deployment rate, for single coils and one size of coils only, and in a single aneurysm model, and (f) only the perpendicular component of the force exerted on the aneurysm wall was measured. We note that this was done intentionally to be able to illustrate the differences between the two coil groups and to create a controlled scenario for a 1:1 comparison between coil types in terms of forces exerted on the aneurysm wall during deployment. Investigation of the effects of aneurysm shapes and the position of the microcatheter on pliability measurement will be subject of future research.
CONCLUSIONS
The in-vitro coil pliability test method quantitatively detects forces exerted on a synthetic aneurysm wall during progressive coil deployment. In a simulated synthetic aneurysm model, the Axium FC and ES coils were found to exert significantly lower forces on the aneurysm wall relative to Stryker 360 Standard and Nano coils respectively.
Supplementary Video Sequential deployment of the Axium ES and Target Nano coils inside the aneurysm. 
